Search

everythinglearnresearchcommunity

for

Search:↓

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Neurosteroids show promise for treating epilepsy and more research is needed.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

Finasteride almost fully depletes allopregnanolone in rat brains and enhances 20α-DHP, but doesn't change 3α-DHP levels.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Finasteride affects alcohol intake in male mice, possibly due to neurosteroids.

Prolactin slows down hair growth in mice.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Women with PMS tend to use suppression more, leading to higher stress levels.

Goat reproductive activity and coat growth are affected by light and temperature, with temperature altering prolactin levels and hair growth, but not melatonin or estrus onset.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Most skin changes during pregnancy go away after giving birth.

Facial dark spots can be caused by the sun, genetics, makeup, or medicine, and are diagnosed by patient history and skin tests.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.